Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 434

1.

A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma.

Bowles DW, Kochenderfer M, Cohn A, Sideris L, Nguyen N, Cline-Burkhardt V, Schnadig I, Choi M, Nabell L, Chaudhry A, Ruxer R, Ucar A, Hausman D, Walker L, Spira A, Jimeno A.

Clin Colorectal Cancer. 2016 Mar 31. pii: S1533-0028(16)30029-9. doi: 10.1016/j.clcc.2016.03.004. [Epub ahead of print]

PMID:
27118441
2.

Integrated Genomics Reveals Convergent Transcriptomic Networks Underlying COPD and IPF.

Kusko RL, Brothers Ii JF, Tedrow J, Pandit K, Huleihel L, Perdomo C, Liu G, Juan-Guardela B, Kass D, Zhang S, Lenburg M, Martinez F, Quackenbush J, Sciurba F, Limper A, Geraci M, Yang I, Schwartz DA, Beane J, Spira A, Kaminski N.

Am J Respir Crit Care Med. 2016 Apr 22. [Epub ahead of print]

PMID:
27104832
3.

Early events in the molecular pathogenesis of lung cancer.

Kadara H, Scheet P, Wistuba II, Spira AE.

Cancer Prev Res (Phila). 2016 Mar 22. pii: canprevres.0400.2015. [Epub ahead of print]

PMID:
27006378
4.

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.

Fehrenbacher L, Spira A, Ballinger M, Kowanetz M, Vansteenkiste J, Mazieres J, Park K, Smith D, Artal-Cortes A, Lewanski C, Braiteh F, Waterkamp D, He P, Zou W, Chen DS, Yi J, Sandler A, Rittmeyer A; POPLAR Study Group.

Lancet. 2016 Mar 9. pii: S0140-6736(16)00587-0. doi: 10.1016/S0140-6736(16)00587-0. [Epub ahead of print]

PMID:
26970723
5.

Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility.

Piccolo SR, Hoffman LM, Conner T, Shrestha G, Cohen AL, Marks JR, Neumayer LA, Agarwal CA, Beckerle MC, Andrulis IL, Spira AE, Moos PJ, Buys SS, Johnson WE, Bild AH.

Mol Syst Biol. 2016 Mar 10;12(3):860. doi: 10.15252/msb.20156506.

6.

Measures of Sleep-Wake Patterns and Risk of Mild Cognitive Impairment or Dementia in Older Women.

Diem SJ, Blackwell TL, Stone KL, Yaffe K, Tranah G, Cauley JA, Ancoli-Israel S, Redline S, Spira AP, Hillier TA, Ensrud KE.

Am J Geriatr Psychiatry. 2016 Mar;24(3):248-58. doi: 10.1016/j.jagp.2015.12.002. Epub 2016 Jan 29.

PMID:
26964485
7.

Sleep Duration and Subsequent Cortical Thinning in Cognitively Normal Older Adults.

Spira AP, Gonzalez CE, Venkatraman VK, Wu MN, Pacheco J, Simonsick EM, Ferrucci L, Resnick SM.

Sleep. 2016 Feb 29. pii: sp-00308-15. [Epub ahead of print]

PMID:
26951390
8.

Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial.

Petrylak DP, Tagawa ST, Kohli M, Eisen A, Canil C, Sridhar SS, Spira A, Yu EY, Burke JM, Shaffer D, Pan CX, Kim JJ, Aragon-Ching JB, Quinn DI, Vogelzang NJ, Tang S, Zhang H, Cavanaugh CT, Gao L, Kauh JS, Walgren RA, Chi KN.

J Clin Oncol. 2016 May 1;34(13):1500-9. doi: 10.1200/JCO.2015.65.0218. Epub 2016 Feb 29.

PMID:
26926681
9.

Clinical Utility of a Bronchial Genomic Classifier in Patients with Suspected Lung Cancer.

Vachani A, Whitney DH, Parsons EC, Lenburg M, Ferguson JS, Silvestri GA, Spira A.

Chest. 2016 Feb 16. pii: S0012-3692(16)01255-1. doi: 10.1016/j.chest.2016.02.636. [Epub ahead of print]

10.

The Case for a Pre-Cancer Genome Atlas (PCGA).

Campbell JD, Mazzilli SA, Reid ME, Dhillon SS, Platero S, Beane J, Spira AE.

Cancer Prev Res (Phila). 2016 Feb;9(2):119-24. doi: 10.1158/1940-6207.CAPR-16-0024. Epub 2016 Feb 1.

PMID:
26839336
11.

Transforming Cancer Prevention through Precision Medicine and Immune-oncology.

Kensler TW, Spira A, Garber JE, Szabo E, Lee JJ, Dong Z, Dannenberg AJ, Hait WN, Blackburn E, Davidson NE, Foti M, Lippman SM.

Cancer Prev Res (Phila). 2016 Jan;9(1):2-10. doi: 10.1158/1940-6207.CAPR-15-0406.

PMID:
26744449
12.

Network Analysis of Lung Transcriptomics Reveals a Distinct B Cell Signature in Emphysema.

Faner R, Cruz T, Casserras T, López-Giraldo A, Noell G, Coca I, Tal-Singer R, Miller B, Rodriguez-Roisin R, Spira A, Kalko SG, Agusti A.

Am J Respir Crit Care Med. 2016 Jan 6. [Epub ahead of print]

PMID:
26735770
13.

Trends in prescribing of sedative-hypnotic medications in the USA: 1993-2010.

Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R.

Pharmacoepidemiol Drug Saf. 2015 Dec 29. doi: 10.1002/pds.3951. [Epub ahead of print]

PMID:
26711081
14.

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.

Ou SH, Ahn JS, De Petris L, Govindan R, Yang JC, Hughes B, Lena H, Moro-Sibilot D, Bearz A, Ramirez SV, Mekhail T, Spira A, Bordogna W, Balas B, Morcos PN, Monnet A, Zeaiter A, Kim DW.

J Clin Oncol. 2016 Mar 1;34(7):661-8. doi: 10.1200/JCO.2015.63.9443. Epub 2015 Nov 23.

PMID:
26598747
15.

Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility.

Piccolo SR, Andrulis IL, Cohen AL, Conner T, Moos PJ, Spira AE, Buys SS, Johnson WE, Bild AH.

BMC Med Genomics. 2015 Nov 4;8:72. doi: 10.1186/s12920-015-0145-6.

16.

Gene-expression profiling of buccal epithelium among non-smoking women exposed to household air pollution from smoky coal.

Wang TW, Vermeulen RC, Hu W, Liu G, Xiao X, Alekseyev Y, Xu J, Reiss B, Steiling K, Downward GS, Silverman DT, Wei F, Wu G, Li J, Lenburg ME, Rothman N, Spira A, Lan Q.

Carcinogenesis. 2015 Dec;36(12):1494-501. doi: 10.1093/carcin/bgv150. Epub 2015 Oct 14.

PMID:
26468118
17.

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

Demetri GD, von Mehren M, Jones RL, Hensley ML, Schuetze SM, Staddon A, Milhem M, Elias A, Ganjoo K, Tawbi H, Van Tine BA, Spira A, Dean A, Khokhar NZ, Park YC, Knoblauch RE, Parekh TV, Maki RG, Patel SR.

J Clin Oncol. 2016 Mar 10;34(8):786-93. doi: 10.1200/JCO.2015.62.4734. Epub 2015 Sep 14.

PMID:
26371143
18.

The SBSM Guide to Actigraphy Monitoring: Clinical and Research Applications.

Ancoli-Israel S, Martin JL, Blackwell T, Buenaver L, Liu L, Meltzer LJ, Sadeh A, Spira AP, Taylor DJ.

Behav Sleep Med. 2015;13 Suppl 1:S4-S38. doi: 10.1080/15402002.2015.1046356. No abstract available.

PMID:
26273913
19.

Update in Lung Cancer 2014.

Spira A, Halmos B, Powell CA.

Am J Respir Crit Care Med. 2015 Aug 1;192(3):283-94. doi: 10.1164/rccm.201504-0756UP. Review.

PMID:
26230235
20.

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.

Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy G, Kazarnowicz A, Park K, Schumann C, Reck M, Depenbrock H, Nanda S, Kruljac-Letunic A, Kurek R, Paz-Ares L, Socinski MA; SQUIRE Investigators.

Lancet Oncol. 2015 Jul;16(7):763-74. doi: 10.1016/S1470-2045(15)00021-2. Epub 2015 Jun 1.

PMID:
26045340
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk